The Journal of Phytopharmacology, 2021;10(2):114-116 ; DOI:10.31254/phyto.2021.10207
Adverse Events of Paediatric Immunization
Yogesh Chand Yadav1 , Anshika2 , Satendra Kumar3
1. Department of Pharmacology, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Saifai, Etawah – 206130, Uttar Pradesh, India
2. Research Scholar, Department of Pharmacology, Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut- 250005, Uttar Pradesh, India
3. B. Pharm, Faculty of Pharmacy, UP University of Medical Sciences, Etawah – 206130, Uttar Pradesh, India
*Author to whom correspondence should be addressed.
Received: 21st December, 2020 / Accepted: 15th January, 2021
Introduction: Immunisation is a cost-effective program for vaccine preventable disease, but adverse events are unexpectedly noticeable especially when the vaccine was apparently healthy at the time of immunization, that’s why a lot of efforts are taken to ensure the safety of vaccine by monitoring the Adverse Event Following Immunization (AEFI) after vaccination. Method: A record based descriptive study was conducted at in hospital of Uttar Pradesh university medical sciences (UPUMS), Saifai, Etawah in 2019 with a total of 1400 vaccinated enrolled children are analysed the data. Result: The study revealed that OPV was the most frequently administered vaccine among the study population of all vaccine doses followed by Pentavalent and BCG vaccine. Fever (85%) was the first most commonly noted incidence related to the all Adverse Event Following Immunization of the vaccine along with persistent crying (20%) is also noted with the administration of vaccine. Conclusion: it was concluded that immunisation program is done for boosting and developing immune system and it start from the birth and the observed AEFI was non serious.
Immunization, Adverse event, Vaccine, Vaccine safety.
HOW TO CITE THIS ARTICLE
Yadav YC, Anshika, Kumar S. Adverse Events of Paediatric Immunization. J Phytopharmacol 2021; 10(2):114-116.
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.